2-73449834-C-G
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001378454.1(ALMS1):c.3307C>G(p.Pro1103Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000286 in 1,613,946 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001378454.1 missense
Scores
Clinical Significance
Conservation
Publications
- Alstrom syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001378454.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ALMS1 | NM_001378454.1 | MANE Select | c.3307C>G | p.Pro1103Ala | missense | Exon 8 of 23 | NP_001365383.1 | ||
| ALMS1 | NM_015120.4 | c.3307C>G | p.Pro1103Ala | missense | Exon 8 of 23 | NP_055935.4 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ALMS1 | ENST00000613296.6 | TSL:1 MANE Select | c.3307C>G | p.Pro1103Ala | missense | Exon 8 of 23 | ENSP00000482968.1 | ||
| ALMS1 | ENST00000484298.5 | TSL:1 | c.3181C>G | p.Pro1061Ala | missense | Exon 7 of 22 | ENSP00000478155.1 | ||
| ALMS1 | ENST00000684548.1 | c.2926C>G | p.Pro976Ala | missense | Exon 6 of 21 | ENSP00000507421.1 |
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152152Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000571 AC: 142AN: 248472 AF XY: 0.000556 show subpopulations
GnomAD4 exome AF: 0.000278 AC: 406AN: 1461794Hom.: 0 Cov.: 40 AF XY: 0.000287 AC XY: 209AN XY: 727196 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000361 AC: 55AN: 152152Hom.: 0 Cov.: 33 AF XY: 0.000377 AC XY: 28AN XY: 74330 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:3
ALMS1: BP4
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Reported as heterozygous in an individual with dilated cardiomyopathy in published literature (PMID: 32746448); This variant is associated with the following publications: (PMID: 32746448)
not specified Uncertain:1Benign:1
Variant summary: ALMS1 c.3304C>G (p.Pro1102Ala) results in a non-conservative amino acid change located in the Alstrom syndrome repeat domain (IPR040972) of the encoded protein sequence. Three of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00057 in 248472 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in ALMS1 causing Cardiomyopathy (0.00057 vs 0.0022), allowing no conclusion about variant significance. c.3304C>G has been reported in the literature in the heterozygous state in at least one individual affected with Cardiomyopathy who also carried a rare missense variant in ALPK3 (e.g. Burstein_2021) . These report(s) do not provide unequivocal conclusions about association of the variant with Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 32746448). ClinVar contains an entry for this variant (Variation ID: 459864). Based on the evidence outlined above, the variant was classified as uncertain significance.
The p.Pro1104Ala variant in ALMS1 is classified as benign because it has been identified in 1.1% (121/10324) of Ashkenazi Jewish chromosomes by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BA1.
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Alstrom syndrome Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at